!!! DISCUSSION GROUP RULES !!!

1. You must be a registered website user in order to post and comment. Guests may read only.
2. Be kind and helpful, not rude and cynical.
3. Don't advertise or promote anything. You will be banned from the group.
4. Report problems to the moderators. THANK YOU!

New treatment option just approved by FDA.

More
4 months 4 weeks ago #73974 by Itpjourney
www.news.sanofi.us/2025-08-29-Sanofis-Wayrilz-approved-in-US-as-first-BTK-inhibitor-for-immune-thrombocytopenia

Seems to be only available to "you" if you have failed on another treatment. Does that mean just Retuximab or TPO agonist drugs, as far as other treatments?

It beats the placebo, so sometimes works...

Please Log in or Create an account to join the conversation.

More
4 months 3 weeks ago - 4 months 3 weeks ago #73980 by Itpjourney
Replied by Itpjourney on topic New treatment option just approved by FDA.
This does sound exciting;  www.medpagetoday.com/meetingcoverage/ashhematology/113278

To reduce auto-antibodies... Sorry, I had a page that did not require sign-up...

Please Log in or Create an account to join the conversation.

You’re not alone. We have answers! Contact PDSA to connect with life altering information, resources and referrals. 440.746.9003 (877.528.3538 toll-free) or PDSA@PDSA.org.

Platelet Disorder Support Association

Platelet Disorder Support Association
8751 Brecksville Road Suite 150
Cleveland, OH 44141
440.746.9003  |  pdsa@pdsa.org
The Platelet Disorder Support Association is a 501(c)3 organization and donations are tax deductible to the fullest extent allowed by law.

IMPORTANT!

The Platelet Disorder Support Association does not provide medical advice or endorse any medication, vitamins or herbs. The information contained herein is not intended nor implied to be a substitute for professional medical advice and is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment, discontinuing an existing treatment and to discuss any questions you may have regarding your unique medical condition.